Works matching IS 03065251 AND DT 2005 AND VI 59 AND IP 5
Results: 21
Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 593, doi. 10.1111/j.1365-2125.2005.02339.x
- By:
- Publication type:
- Article
Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 598, doi. 10.1111/j.1365-2125.2005.02340.x
- By:
- Publication type:
- Article
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 495, doi. 10.1111/j.1365-2125.2005.02342.x
- By:
- Publication type:
- Article
Laser Doppler imager (LDI) scanner and intradermal injection forin vivopharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 511, doi. 10.1111/j.1365-2125.2004.02344.x
- By:
- Publication type:
- Article
Fexofenadine pharmacokinetics are associated with a polymorphism of theSLCO1B1gene (encoding OATP1B1).
- Published in:
- 2005
- By:
- Publication type:
- Letter
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 564, doi. 10.1111/j.1365-2125.2005.02355.x
- By:
- Publication type:
- Article
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 588, doi. 10.1111/j.1365-2125.2005.02356.x
- By:
- Publication type:
- Article
Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 536, doi. 10.1111/j.1365-2125.2005.02357.x
- By:
- Publication type:
- Article
Khat chewing is a risk factor for acute myocardial infarction: a case-control study.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 574, doi. 10.1111/j.1365-2125.2005.02358.x
- By:
- Publication type:
- Article
Statins, lack of energy and ubiquinone.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Determination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 542, doi. 10.1111/j.1365-2125.2005.02360.x
- By:
- Publication type:
- Article
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 582, doi. 10.1111/j.1365-2125.2005.02361.x
- By:
- Publication type:
- Article
Brugada-like ECG abnormalities during thioridazine overdose.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 520, doi. 10.1111/j.1365-2125.2005.02363.x
- By:
- Publication type:
- Article
Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 552, doi. 10.1111/j.1365-2125.2005.02364.x
- By:
- Publication type:
- Article
Handbook of Analytical Separations, Vol. 5: Drug Monitoring and Clinical Chemistry.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx<sup>®</sup> insulin Diabetes Management System.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 546, doi. 10.1111/j.1365-2125.2005.02366.x
- By:
- Publication type:
- Article
Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 524, doi. 10.1111/j.1365-2125.2005.02368.x
- By:
- Publication type:
- Article
Dutch Society of Clinical Pharmacology and Biopharmacy Meeting of October 8th 2004.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 609, doi. 10.1111/j.1365-2125.2005.02401.x
- Publication type:
- Article
Proceedings of the British Pharmacological Society Clinical Pharmacology Section 14–16 December 2004.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 5, p. 624, doi. 10.1111/j.1365-2125.2005.02402.x
- Publication type:
- Article
Biomarkers and surrogate endpoints.
- Published in:
- 2005
- By:
- Publication type:
- Editorial